Renal care provider Diaverum is entering China through a JV with state-owned conglomerate Yueda. The group is planning to build a network, initially in a handful of provinces including Jiangsu and Guangdong citing huge demand and decent public reimbursement schemes. We speak to Mans Olsson, Head of Middle East and Asia.



